Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US FDA explains reaccreditation of third party device reviewers; aligns with IMDRF

This article was originally published in Clinica

Executive Summary

The US FDA has issued a draft guideline on new requirements relating to the third party firms that the agency accredits to review medical device submissions, including an obligation for these firms to apply for reaccredition.

Advertisement

Topics

UsernamePublicRestriction

Register